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ABSTRACT 
Osteomyelits due to concurrent multi-drug resistance organisms is difficult to treat for 
any surgeon and infectious disease physician. An eleven-year-old boy presenting with an open 
fracture of the left radius and ulna after a fall in a stagnant wet field. Despite prophylactic 
antibiotics and surgical intervention, the open wound was infected, and Chromobacterium 
violaceum as well as Klebsiella pneumoniae were isolated. He was treated with six weeks 
of parenteral cefepime and amikacin and was discharged upon clinical improvement. 
Unfortunately, chronic osteomyelitis set in with persistent sinus drainage. He then underwent 
a second procedure for debridement of the wound and Burkholderia pseudomallei was 
isolated. Parenteral antibiotic therapy was initiated progressing with a marked improvement. 
However, the long course of antibiotics had exhausted the patient and his family, leading to a 
premature interruption of the parenteral antibiotic. Despite the suboptimal antibiotic course, 
there were no signs of relapsed osteomyelitis during subsequent review. The timely surgical 
intervention with appropriate sampling for subsequent microorganism isolation guided the 
suitability of the treatment line. 
KEYWORDS: Osteomyelitis. Multi-drug resistance (MDR) organisms. Burkholderia 
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BACKGROUND 
Chromobacterium violaceum is a gram-negative, facultative anaerobic 
coccobacillus widely distributed in the soil and waterfalls of tropical rainforest in 
Malaysia1,2. Humans are exposed to C. violaceum through multiple routes including 
direct intake of contaminated water, exposure of wounds to contaminated sources, 
or through contaminated medical equipment. Reported cases of human infections 
are rare and normally associated with a high fatality rate, due to the ability of the 
disease to rapidly deteriorate within 72 h, progressing to severe sepsis with metastatic 
abscesses in multiple organs, then to septic shock and ultimately to death3. Even with 
the timely initiation of the antibiotic treatment, relapses may occur if inadequate 
antibiotics are used or discontinued prematurely or, in the presence of abscesses, 
due to viable microorganisms that still remain in the abscess cavity even after the 
end of the antibiotics therapy4. 
Burkholderia pseudomallei is a gram-negative bacterium that causes melioidosis. 
It is especially prevalent in South East Asia countries including Malaysia, Thailand, 
Vietnam and Singapore5. The bacterium is intrinsically multi-drug resistant, but 
prolonged treatment with appropriate combinations of antibiotics is normally 
sufficient to eradicate the infection. Patients with diabetes mellitus, chronic 
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renal disease and immunocompromised conditions are 
at higher risk for melioidosis6. The overall fatality rate 
among patients diagnosed with melioidosis remains 
significantly high despite the use of recommended standard 
antibacterial agents for therapy, highlighting the importance 
of early identification and intervention. Thus, we present 
a case that is, to our knowledge, the first documented 
case reporting on an open fracture infection due to rare 
tropical microorganisms involving C. violaceum and 
B. pseudomallei.
CASE REPORT 
An 11-year-old Malay boy was presented to the 
Emergency Department (ED) with a chief complaint of 
pain on his left upper limb due to an alleged fall from a 
monkey bar at school onto accumulated stagnant water. 
At ED, he was diagnosed with an open fracture in the left 
radius and ulna. Immediate irrigation and immobilization of 
the fractured forearm were performed. His vital signs were 
stable. The patient was then given a dose of intravenous 
(IV) cefuroxime 750 mg, paracetamol syrup 390 mg and 
intramuscular (IM) tetanus toxoid 0.5 mg. 
The patient had no history of chronic illnesses or 
allergies to any food or medications. The growth and 
development of the child were uneventful. The wound 
debridement was carried out and an intramedullary K-wire 
was inserted in both, radius and ulna, on the next day after 
the patient’s admission. The radiograph of the post wound 
debridement and intramedullary K-wire insertion in the left 
radius and ulna showed acceptable reduction and fixation of 
the bones (Figure 1). The patient began antibiotic therapy 
with IV cefuroxime 650 mg three times daily in the ward. 
Despite the successful surgery, the patient started to have 
multiple fever episodes on day 5 of admission and other 
parameters suggestive of infection. The laboratory findings 
during admission were reported in Table 1. Upon wound 
inspection, there was pouring of pus over the debrided 
wound. The wound debridement was repeated in view 
of the persistent sero-purulent discharge on the seventh 
day, with ulna intra-medullary K-wire removed and the 
radius K-wire retained. A tissue biopsy and a samples 
of pus were sent to culture and sensitivity (C&S) tests 
were repeated during the wound debridement. The results 
revealed the presence of K. pneumoniae and C. violaceum 
infection. C&S showed that K. pneumoniae was sensitive to 
cefuroxime, gentamicin and amikacin, while C. violaceum 
was sensitive to ciprofloxacin, gentamicin and cefepime, but 
resistant to ceftazidime and piperacillin/ tazobactam. The 
primary team decided to change to a definitive treatment 
with IV ciprofloxacin 260 mg twice daily based on the C&S 
Table 1 - Laboratory findings of the patient during the first admission.
Laboratory parameters and reference 
ranges
Date 
7/3/2019 7/7/19 7/8/2019 7/16/2019 7/23/2019 8/5/2019
TWCC 4-11 × 109/L 7.2 5.8 10.7 12.0 8.8 5.9
Hb 11.5-16.5 g/100 mL 12.7 7.0 11.8 10.1 11.8 10.9
Platelet 150-400 × 109/L 317 168 330 631 603 309
Albumin 35-50 g/L - - - 35 39.4 40.5
ALP 53-141 IU/L - - - 180 226 243
CRP < 10 mg/L - - - 75.4 15.5 4.2
TWCC = Total white cell count; Hb = Hemoglobin; ALP = Alkaline phosphatase; CRP = C-reactive protein
Figure 1 - Radiograph of post wound debridement and 
insertion of intramedullary K-Wire in the left radius and ulna 
with acceptable reduction and fixation.
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results, meantime awaiting the decision of the infectious 
disease physician. 
An abdominal ultrasound was carried out after the 
identification of C. violaceum to rule out the dissemination 
of the infection. The ultrasound revealed a segment V liver 
lesion measuring 1.3 cm x 0.8 cm x 1.3 cm corresponding 
to an early liver abscess, an enlarged liver expansion, 
measuring 15.9 cm. The patient’s liver function test (LFT) 
has also shown a rise of alkaline phosphatase (ALP). 
After the pediatric infectious disease team evaluation, the 
antibiotic was changed to IV cefepime 1.4 g three times 
daily and IV amikacin 420 mg once daily in view of the 
risk of irreversible bone and joint damage due to the use 
of fluoroquinolones in a young boy. Wound healing and 
epithelialization were observed with no discharges during 
the hospital stay. No adverse effects were reported with the 
use of the current regimen. Repeated swab C&S and blood 
C&S showed no growth of any other microorganisms. IV 
amikacin was continued for two weeks, while IV cefepime 
was administered for up to six weeks. A repeated ultrasound 
prior to discharge showed resolution of the previous liver 
abscess. The patient was discharged with close monitoring 
and follow-up at the outpatient clinic. Unfortunately, one 
month later, a chronic osteomyelitis of ulna set in with 
persistent sinus drainage at the wound site. The radiograph 
showing osteomyelitis of the left ulna with presence of 
periosteal reaction and sequestration is shown in Figure 2.
The patient was readmitted to the ward and underwent 
another wound debridement and sequestrectomy of the left 
ulna. The bone C&S taken during this surgical procedure 
reported the isolation of B. pseudomallei and methicillin 
sensitive Staphylococcus aureus; B. pseudomallei was 
sensitive to ceftazidime, imipenem and doxycycline. 
Thus, IV ceftazidime 1.8 g every four times daily was 
initiated parenterally, with a target duration of six weeks. 
The abdominal ultrasound and the echocardiogram were 
requested to rule out the dissemination of the infection and 
of abscesses or vegetations. The patient was screened for 
immunological abnormalities and for glucose-6-phosphate 
dehydrogenase (G6PD) deficiency and he was found to 
be normal. A marked improvement was shown along the 
course of treatment. However, the long course of antibiotic 
therapy had exhausted the patient and his family, leading 
to premature interruption of the parenteral antibiotic 
administration on day 22. Amoxicillin/ clavulanate tablets 
625 mg three times daily were given as the discharge 
medication to complete a total of 24 weeks. Despite the 
suboptimal parenteral antibiotic course, his wound and hand 
function recovered remarkably well and there were no signs 
of relapsing osteomyelitis upon the subsequent follow-up. 
DISCUSSION 
Our patient presented with a simple, uncomplicated 
open fracture, which underwent a successful surgical 
intervention and an empirical coverage with a parenteral 
antibiotic. However, the poor wound healing raised our 
concern and another wound debridement was performed 
with C&S showing the presence of a rare tropical 
microorganism, C. violaceum. We decided to initially use 
a single agent (ciprofloxacin) due to the lower rates of 
resistance found in the literature7. However, the therapy 
switched to a combination of IV cefepime and amikacin due 
to its proven synergistic effect8 after consulting an infectious 
disease physician and the worry of irreversible joint and 
bone damage secondary to the use of ciprofloxacin9. We 
decided for an extended six weeks duration of parenteral 
antibiotics, as previous cases had shown that a premature 
interruption of antibiotics may result in the relapsing of 
infection and rapid deterioration1,10. The patient responded 
well to the treatments and completely eradicated bacteria 
with no significant adverse events. 
C. violaceum could cause dissemination of infection in 
susceptible individuals leading to liver and lung abscesses 
and fatal sepsis. The ALP of our patient was elevated. 
However, this could be normal for children and adolescents 
due to the development of bones11. Therefore, an abdominal 
ultrasound was requested to rule out the presence of liver 
abscesses. The ultrasound report suggested the possibility 
of an early abscess, thus, a close monitoring of LFT was 
Figures 2 - Radiograph of osteomyelitis of left ulna with 
presence of periosteal reaction and sequestration.
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carried out throughout the hospitalization and the patient’s 
clinical condition was stable, with no signs and symptoms 
of acute liver injury.
The patient’s condition was further complicated when we 
isolated B. pseudomallei from a second wound debridement 
samples. B. pseudomallei is an endemic tropical organism in 
Malaysia, usually isolated in wounds contaminated with soil 
or muddy water12,13. After the previous combination cefepime 
and amikacin, B. pseudomallei and S. aureus should have 
been eradicated, as they were both susceptible to cefepime. 
Thus, we considered the new findings as a sequential 
infection and decided for an initial plan of IV ceftazidime for 
six weeks and continuation of the oral antibiotic for a total of 
24 weeks, as indicated in local guidelines5,14. Nevertheless, 
the patient’s family decided to discharge the boy at their own 
risk, even after being counselled on the potential risks of the 
early discontinuation of antibiotics. Despite the suboptimal 
therapy of only three weeks of the parenteral antibiotic, the 
patient progressed to full recovery. 
In a nutshell, timely intervention, wound debridement, 
repeated wound exploration and appropriate sampling 
for microorganism isolation could guide the suitability of 
treatment. Clinicians should be aware of the potentially 
fatal infections and the need for aggressive antimicrobial 
combinations after the adequate understanding of the 
available laboratory and diagnostic data. This is to prevent 
chronic infections due to opportunistic pathogens leading 
to increase morbidity and functional loss. 
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